Lexaria DehydraTECH(TM) 2.0 Outperforms MCT in 2021 R&D Study
New York, New York–(Newsfile Corp. – May 25, 2021) – PCG Digital –The positive results keep rolling in for Lexaria (LXX). They recently released R&D study results for three new DehydraTECHTM 2.0 formulation variations that significantly outperformed traditional MCT oil-based formulations that have become CBD industry standard.